121 related articles for article (PubMed ID: 31216441)
1. Role of PGRMC1 in cell physiology of cervical cancer.
Shih CC; Chou HC; Chen YJ; Kuo WH; Chan CH; Lin YC; Liao EC; Chang SJ; Chan HL
Life Sci; 2019 Aug; 231():116541. PubMed ID: 31216441
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component 1 is involved in oral cancer cell metastasis.
Huang HY; Chou HC; Law CH; Chang WT; Wen TN; Liao EC; Lin MW; Lin LH; Wei YS; Tsai YT; Chen HY; Tan KT; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Cell Mol Med; 2020 Sep; 24(17):9737-9751. PubMed ID: 32672400
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
4. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
5. Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer.
Lee SR; Lee YH; Jo SL; Heo JH; Kim G; Lee GS; An BS; Baek IJ; Hong EJ
Cell Commun Signal; 2021 Apr; 19(1):42. PubMed ID: 33832499
[TBL] [Abstract][Full Text] [Related]
6. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
12. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
[TBL] [Abstract][Full Text] [Related]
13. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
[No Abstract] [Full Text] [Related]
14. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
15. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
17. Effects of MACC1 siRNA on biological behaviors of HeLa.
Chai H; Yang Y
Arch Gynecol Obstet; 2014 Jun; 289(6):1271-80. PubMed ID: 24346124
[TBL] [Abstract][Full Text] [Related]
18. Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1.
Hampton KK; Anderson K; Frazier H; Thibault O; Craven RJ
Mol Pharmacol; 2018 Jul; 94(1):665-673. PubMed ID: 29674524
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery for neuroendocrine cervical cancer.
Lin LH; Chang SJ; Hu RY; Lin MW; Lin ST; Huang SH; Lyu PC; Chou HC; Lai ZY; Chuang YJ; Chan HL
Electrophoresis; 2014 Jul; 35(14):2039-45. PubMed ID: 24723343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]